BeOne Medicines (ONC) Net Income - Minority (2017 - 2020)
BeOne Medicines (ONC) reported Net Income - Minority of -$9.1 million for Q3 2020, up 42.15% year-over-year from -$6.4 million in Q4 2019, and up 10.57% on a QoQ basis from -$10.2 million in Q2 2020.
BeOne Medicines (ONC) has 4 years of Net Income - Minority data on file, last reported at -$9.1 million in Q3 2020.
- Quarterly Net Income - Minority rose 42.15% year-over-year to -$9.1 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was -$9.1 million (up 42.15% YoY) and the FY2019 annual result came in at -$16.2 million, down 11.8% from the prior year.
- Net Income - Minority grew to -$9.1 million in Q3 2020 per ONC's latest filing, from -$10.2 million in the prior quarter.
- Across five years, Net Income - Minority topped out at -$9.1 million in Q3 2020 and bottomed at -$17.4 million in Q2 2019.
- The 4-year median for Net Income - Minority is -$14.4 million (2017), against an average of -$13.9 million.
- The widest annual swing landed in 2019, when Net Income - Minority retreated 21.36%; it then jumped 42.15% in 2020.
- Tracing ONC's Net Income - Minority over 4 years: stood at -$14.4 million in 2017, then fell by 0.16% to -$14.4 million in 2018, then declined by 11.8% to -$16.2 million in 2019, then jumped by 43.55% to -$9.1 million in 2020.
- Per Business Quant, the three latest ONC Net Income - Minority figures stand at -$9.1 million (Q3 2020), -$10.2 million (Q2 2020), and -$14.8 million (Q1 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -9.12 Mn |
| Jun 30, 2020 | -10.19 Mn |
| Mar 31, 2020 | -14.84 Mn |
| Dec 31, 2019 | -16.15 Mn |
| Sep 30, 2019 | -15.76 Mn |
| Jun 30, 2019 | -17.39 Mn |
| Mar 31, 2019 | -13.91 Mn |
| Dec 31, 2018 | -14.45 Mn |
| Sep 30, 2018 | -12.99 Mn |
| Dec 31, 2017 | -14.42 Mn |